- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A pharmacist alleged a Pfizer commercial account manager discussed pricing for generic losartan before it was licensed. Panel noted a price list…
Complaint alleged a Daiichi-Sankyo rep said a medicines management team would be disbanded, potentially misleading GPs to prescribe Olmetec. Panel couldn’t prove…
Financial Times alleged Roche pressured staff to sell Tamiflu to non-doctors and used cash payments/discounts. Panel found unclear internal guidance/certification issues but…
PMCPA found Bracco in breach after a representative had not completed the ABPI exam within the required timeframe and a CT injector…
A Merz representative set up an Instagram account for business and posted images including a Bocouture pack shot. The Panel ruled this…
Employee alleged reps influenced advisory board invitees, meeting was disguised promotion, and neutropenia discussions compromised safety and PV. Panel had concerns but…
Complaint alleged off-label weight loss/CV superiority promotion for Ozempic. Panel/Appeal Board found no off-label breach, but ruled materials unclear on SUSTAIN 6…
Cephalon’s internal congress feedback note described “clubbing” and late-night bars with HCPs and urged “lets make sure they start Rxing now!”. PMCPA…
Anonymous GP alleged a sponsored contraception update was disguised promotion and that a Bayer representative bullied delegates. Panel found sponsorship was clear…
Bayer posted two product-specific tweets about Levitra and Sativex from press release headlines. The tweets were not certified and were accessible to…
Novo Nordisk’s NovoSeven leavepiece claimed cost-effectiveness vs FEIBA using older efficacy inputs. PMCPA ruled the claim didn’t reflect the totality of evidence…
BMJ analysis suggested Shire had unreported EUCTR trial results. PMCPA found the trials were out of UK Code scope or results were…
Cephalon discovered an interim medical adviser who certified ~45 promotional items was not GMC registered. PMCPA found a breach of Clause 14.1…
A GP challenged a Trajenta launch press release claiming “class-comparable efficacy”. PMCPA ruled the indirect SPC-based comparison was misleading, unsubstantiated and exaggerated.…
PMCPA case AUTH/3120/11/18 (Director v Shire) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.